Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hypogonadism 4Eunuchism 2Testicular Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Klinefelter Syndrome 1Infertility 1Fatigue Syndrome, Chronic 1Carcinoma, Renal Cell 1

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2testosterone undecanoate 1tempol 1TEMPOL-H 1Sirolimus 1Nelfinavir 1Metformin 1Hydroxychloroquine 1Gonadotropins 1Diet, Protein-Restricted 1Dasatinib 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostate Cancer Recurrent × testosterone undecanoate × Clear all
NCT04134130 2020-01-22

The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer

Lund University

Phase NA Completed
33 enrolled
Genitourinary

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡